Active ingredientVinblastineCat. No. P-V045-001CAS 865-21-4Family · Pharmaceutical analytical standards
Vinblastine
An anticancer alkaloid from the Madagascar periwinkle (Catharanthus roseus), isolated in the late 1950s in Canada by Robert Noble and Charles Beer: it blocks cell division and is used against Hodgkin lymphoma and testicular cancer. This family brings together the active ingredient and other impurities.
Did you know?The two researchers were studying the plant as a folk remedy for diabetes: the animals' blood sugar did not change, but their white blood cells dropped sharply, a hint of a possible anticancer drug.
Go to the active ingredient →Active ingredientVinblastineCat. No. P-V045-001CAS 865-21-4
Active ingredientVinblastine SulfateCat. No. P-V045-002CAS 143-67-9
Impurity(-)-ConophyllineCat. No. P-V045-004CAS 142741-24-0
ImpurityVinblastine Impurity BCat. No. P-V045-008CAS 61936-68-3
ImpurityVinblastine Impurity DCat. No. P-V045-010
ImpurityVinblastine Impurity FCat. No. P-V045-012CAS 54081-68-4
ImpurityVinblastine Impurity GCat. No. P-V045-013
ImpurityVinblastine Impurity JCat. No. P-V045-015
ImpurityVinblastine Impurity KCat. No. P-V045-016
ImpurityVinblastine Impurity MCat. No. P-V045-017No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceVinblastine sulfate CRSEDQM code V0300000Family VinblastineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.